Dew, do you really think that GTCB will be able to avoid another round of financing in 2008? Partner or not, they are thin on cash and will need to go to the well in the first half of 2008. The only way they can avoid this is to get a substantial up-front payment. Without US approval, in the bag, I think it is doubtful anyone will commit huge sums for an orpan drug application.
Market Data 
Markets 
AI
